Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis C

被引:29
|
作者
Miura, Mika [1 ]
Maekawa, Shinya [1 ]
Kadokura, Makoto [1 ]
Sueki, Ryota [1 ]
Komase, Kazuki [1 ]
Shindo, Hiroko [1 ]
Ohmori, Takako [1 ]
Kanayama, Asuka [1 ]
Shindo, Kuniaki [1 ]
Amemiya, Fumitake [1 ]
Nakayama, Yasuhiro [1 ]
Kitamura, Takatoshi [1 ]
Uetake, Tomoyoshi [1 ]
Inoue, Taisuke [1 ]
Sakamoto, Minoru [1 ]
Okada, Shunichi [1 ]
Enomoto, Nobuyuki [1 ]
机构
[1] Univ Yamanashi, Fac Med, Dept Internal Med 1, Chuo Ku, Yamanashi 4093898, Japan
关键词
HCV; HCC; Core; IL28B; VIRUS GENOTYPE 1B; CORE PROTEIN; COMBINATION THERAPY; IMPORTANT PREDICTOR; RIBAVIRIN THERAPY; GENETIC-VARIATION; OXIDATIVE STRESS; LIVER-DISEASE; INTERFERON; REGION;
D O I
10.1007/s12072-011-9307-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims The association between hepatitis C virus (HCV) sequences with interleukin 28B (IL28B) single-nucleotide polymorphism (SNP) in the development of hepatocellular carcinoma (HCC) has not been well clarified. Methods Complete HCV open-reading frame sequences were determined in 20 patients developing HCC and 23 non-HCC patients with HCV-1b infection in two distant time points. An additional 230 patients were studied cross-sectionally for core and NS5A sequences with HCC development. Among them, 98 patients with available samples were investigated for changes in viral core sequences over time. Finally, IL28B SNPs and HCC development were investigated in 228 patients. Results During observation period (HCC for 10.8 years, and non-HCC for 11.1 years), changes in core a. a. 70 and three amino acid positions in NS5A were characteristics of the patients developing HCC. In 230 patients, Q (glutamine) or H (histidine) to R (arginine) ratio at core a. a. 70 was significantly higher in the HCC group (HCC group 43: 22 vs. non-HCC group 66: 99, p = 0.001). A change in core R70Q was observed over time in 11 patients associated with a decrease in platelets (p = 0.005) and albumin (p = 0.005), while a Q70R change was observed in 4 patients without associated changes in platelets (nonsignificant) and albumin (nonsignificant). IL28B SNP showed significant correlation with the core a. a. 70 residue. There was no evident link between IL28B SNPs and the occurrence of HCC. Conclusions Hepatitis C virus core a. a. 70 residue is associated with liver disease progression and is independent factor for HCC development in genotype-1b infection. IL28B SNPs are related to core a. a. 70 residue, but not to HCC. The functional relevance of core a. a. 70 residue in hepatitis C pathogenesis should be further investigated.
引用
收藏
页码:386 / 396
页数:11
相关论文
共 50 条
  • [21] IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C
    Ciesla, Andrzej
    Bociaga-Jasik, Monika
    Sobczyk-Krupiarz, Iwona
    Glowacki, Mikolaj K.
    Owczarek, Danuta
    Cibor, Dorota
    Sanak, Marek
    Mach, Tomasz
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (35) : 4892 - 4897
  • [22] Association of Serum Adipocytokines With IL28B and SVR in Chronic Hepatitis C
    Clark, Paul J.
    Thompson, Alexander J.
    Jazwinski, Alison
    Tillmann, Hans L.
    Naggie, Susanna
    Muir, Andrew J.
    Patel, Keyur
    GASTROENTEROLOGY, 2012, 142 (05) : S968 - S969
  • [23] IL28B polymorphisms and treatment of hepatitis C
    Clark P.J.
    Thompson A.J.V.
    Muir A.J.
    Current Hepatitis Reports, 2011, 10 (1) : 70 - 78
  • [24] IL28B GENETIC VARIANTS ARE NOT ASSOCIATED WITH SERUM IL28B LEVELS IN ADULTS WITH CHRONIC HEPATITIS C. PILOT STUDY
    Bialkowska, J.
    Szemraj, J.
    Jablkowski, M.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S321 - S321
  • [25] IL28B MINOR ALLELE IS AN INDEPENDENT RISK FACTOR FOR EARLY-AGE ONSET OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C
    Sato, Masaya
    Kato, Naoya
    Tateishi, Ryosuke
    Muroyama, Ryosuke
    Kowatari, Norie
    Li, Wenwen
    Goto, Kaku
    Otsuka, Motoyuki
    Shiina, Shuichiro
    Yoshida, Haruhiko
    Koike, Kazuhiko
    HEPATOLOGY, 2011, 54 : 565A - 565A
  • [26] IL28B GENETIC ATTRIBUTABLE RISK IN HEPATITIS C-ASSOCIATED HEPATOCELLULAR CARCINOMA AND DECOMPENSATED LIVER DISEASE
    O'Brien, T. R.
    Morgan, T. R.
    Pfeiffer, R. M.
    Chung, R. T.
    Lok, A. S.
    Shiffman, M. L.
    Dotrang, M.
    Sninsky, J. J.
    Bonkovsky, H. L.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S527 - S528
  • [27] EXPLORATION OF SERUM ADIPOCYTOKINE ASSOCIATIONS WITH IL28B GENOTYPE IN CHRONIC HEPATITIS C
    Clark, P. J.
    Thompson, A. J.
    Tillmann, H. L.
    Jazwinski, A.
    Naggie, S.
    Muir, A. J.
    Patel, K.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S344 - S344
  • [28] The influence of IL28B polymorphisms on treatment response in patients with chronic hepatitis C
    Svorcan, Petar
    Lazarevic, Ivana
    Delic, Dragan
    Jovanovic, Tanja
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 206 - 206
  • [29] Complicated Relationships of Amino Acid Substitution in Hepatitis C Virus Core Region and IL28B Genotype Influencing Hepatocarcinogenesis
    Akuta, Norio
    Suzuki, Fumitaka
    Seko, Yuya
    Kawamura, Yusuke
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Hara, Tasuku
    Kobayashi, Mariko
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    HEPATOLOGY, 2012, 56 (06) : 2134 - 2141
  • [30] Role of IL28B for chronic hepatitis C treatment toward personalized medicine
    Matsuura, Kentaro
    Watanabe, Tsunamasa
    Tanaka, Yasuhito
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (02) : 241 - 249